Abbott Won’t Shrink From Competitor Merck’s Cordaptive
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.